Status:

COMPLETED

Incorporating CV Risk Assessment in AYA Visits

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Eligibility:

All Genders

13+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the web tool #HerHeart's usability and feasibility in adolescent and young adult women (AYA) and the opinion of their healthcare providers (HCP).

Detailed Description

The objective of the proposed research is to increase young women's perceived susceptibility to CVD and provide a cue to action to adopt heart-healthy behaviors. The aim of the proposed study is to ev...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (AYAs):
  • Patient at CHOA Hughes Spalding Adolescent Medicine Practice or the Grady Health System Teen Program
  • Age 13-21 years
  • Self-identifying as non-Hispanic Black or White race (inclusive of Hispanic ethnicity)
  • Self-identifying as female
  • Visit type is annual wellness/health check, behavioral/mental health, or reproductive/gynecological health
  • Consistent access to a mobile device with internet capability
  • Exclusion Criteria (AYAs):
  • Cognitive impairment limiting ability to complete study procedure
  • Spoken and written language other than English
  • Diagnosis of hypertension, diabetes, or hyperlipidemia requiring medications, or atherosclerotic cardiovascular disease
  • Past or current diagnosis of a DSM-V eating disorder
  • Diagnosis of schizophrenia, bipolar disorder, or psychiatric hospitalization in the past 12 months
  • Pregnant at the time of the study.
  • Inclusion Criteria (HCPs) to complete feasibility surveys:
  • Clinical team member (physician or nurse practitioner, nurse, social worker, psychologist, health educator, medical assistant, dietitian) at the CHOA Hughes Spalding Adolescent Medicine Practice or the Grady Health System Teen Program
  • Practicing at one of the study sites at least twice per month on average over the past year
  • Exclusion Criteria (HCPs)
  • Member of the research study team

Exclusion

    Key Trial Info

    Start Date :

    July 1 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 3 2023

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT05384834

    Start Date

    July 1 2022

    End Date

    April 3 2023

    Last Update

    October 13 2023

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Children's Healthcare of Atlanta - Hughes Spalding Research Room

    Atlanta, Georgia, United States, 30303

    2

    Grady Health System

    Atlanta, Georgia, United States, 30303

    Incorporating CV Risk Assessment in AYA Visits | DecenTrialz